Placebo Ocular Insert

DEVICE2 trials

Sponsors

ForSight Vision5, Inc.

Conditions

Ocular HypertensionPrimary Open-Angle Glaucoma

Phase 2

Bimatoprost Ocular Insert Compared to Topical Timolol Solution in Patients With Glaucoma or Ocular Hypertension

CompletedNCT01915940

ForSight Vision5, Inc.Ocular Hypertension, Primary Open-Angle Glaucoma

Start: 2013-10-23End: 2014-11-14Updated: 2018-04-20

Dose-Ranging Study of the Bimatoprost Ocular Insert

CompletedNCT02358369

ForSight Vision5, Inc.Ocular Hypertension, Primary Open-Angle Glaucoma

Start: 2015-01-19End: 2015-10-07Updated: 2020-06-04

Related Papers

Sustained release glaucoma therapies: Novel modalities for overcoming key treatment barriers associated with topical medications.

2022-12-0130 citations